Tag: Prescription Drugs
Mifepristone Pre-Tx Improves Management of Early Miscarriage
Successful management likely for pretreatment with mifepristone followed by misoprostol
FDA: Opioid Antidote Naloxone Recalled
Two lots of Naloxone recalled due to potential presence of particulate matter in syringe plunger
ASCO: Pembrolizumab Superior for Initial Tx of Advanced NSCLC
Improved overall survival versus chemotherapy regardless of the PD-L1 tumor proportion score
ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer
Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival
Oral Propranolol Seems Safe for Infantile Hemangioma
Good safety profile for children with infantile hemangioma with no prespecified underlying disease
Galcanezumab Beats Placebo for Episodic Migraine
Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
Oral Propranolol Seems Safe for Infantile Hemangioma
Good safety profile for children with infantile hemangioma with no prespecified underlying disease
Galcanezumab Beats Placebo for Episodic Migraine
Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
Elevated HbA1c Usually Leads to Prompt Tx Start, Intensification
Within 6 months of elevated HbA1c, rate of initiation 63 percent, rate of intensification 82 percent
Certolizumab Looks Promising for Moderate-to-Severe Psoriasis
Higher-dose certolizumab (400 mg) better at cutting symptoms than low-dose (200 mg)
